GlassScriptPhysician profile
Stephanie A Gorham
NPI 1023239258
$1,079.06
in general payments reported to CMS, 2019-2025
19 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $117 · 2024: $127 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $251.35 | 2019-2024 | Linx Reflux Management System, Enseal, Harmonic |
| Pfizer INC. | $172.83 | 2019-2020 | |
| Amgen INC. | $156.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.84 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $45.62 | 2019-2020 | |
| Amarin Pharma, INC. | $44.79 | 2019-2020 | |
| Novo Nordisk INC | $43.30 | 2019-2020 | |
| Lilly USA, LLC | $38.30 | 2019 | |
| Astellas Pharma US INC | $26.01 | 2019 | |
| Genentech USA, INC. | $22.85 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.97 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.63 | 2019 | |
| Merck Sharp & Dohme LLC | $13.02 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.86 | 2019 | |
| Shire North American Group INC | $12.85 | 2019 | |
| Allergan, INC. | $12.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Gorham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.